
Sign up to save your podcasts
Or


Moderator: Barbara Tettenborn (St. Gallen, Switzerland)
Guest: Thomas Meinel (Bern, Switzerland)
Thomas Meinel, a clinician scientist at the Burn Stroke Research Center in Switzerland, is hosted by Barbara Tettenborn as they discuss covert cerebrovascular disease. His research, particularly on strokes in patients on anticoagulation, is explored, highlighting the frequency and clinical implications of covert cerebrovascular lesions. Meinel emphasizes the current lack of clear evidence for managing these conditions. He also shares insights into ongoing studies that aim to connect epidemiological knowledge with clinical practices, encouraging neurologists to recognize and address covert cerebrovascular disease in patient care.
By ean.orgModerator: Barbara Tettenborn (St. Gallen, Switzerland)
Guest: Thomas Meinel (Bern, Switzerland)
Thomas Meinel, a clinician scientist at the Burn Stroke Research Center in Switzerland, is hosted by Barbara Tettenborn as they discuss covert cerebrovascular disease. His research, particularly on strokes in patients on anticoagulation, is explored, highlighting the frequency and clinical implications of covert cerebrovascular lesions. Meinel emphasizes the current lack of clear evidence for managing these conditions. He also shares insights into ongoing studies that aim to connect epidemiological knowledge with clinical practices, encouraging neurologists to recognize and address covert cerebrovascular disease in patient care.

503 Listeners

301 Listeners

9 Listeners

55 Listeners

1,150 Listeners

24 Listeners

517 Listeners

136 Listeners

10 Listeners

251 Listeners

189 Listeners

6 Listeners

29,378 Listeners

0 Listeners

84 Listeners